Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Thomas Eleveld

Thomas Eleveld

Postdoc

Looijenga groep

Telefoon 088 97 25 614

E-mail t.f.eleveld@prinsesmaximacentrum.nl

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q
- aug. 2024
- Dylan, Stavish, et al
- Stem Cell Reports
Translation research on testicular germ cell tumors.
- jun. 2023
- Thomas, Eleveld, et al
- Tijdschrift voor Urologie
Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk
- jan. 2023
- Sanne, Hillenius, et al
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
- jan. 2023
- Thomas F, Eleveld, et al
- Frontiers in Oncology
Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma
- sep. 2022
- Kaylee M., Keller, et al
- Frontiers in Oncology

Bekijk alle publicaties

Thomas Eleveld

Publicaties

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q

Translation research on testicular germ cell tumors.

Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma